Another test to help clinicians diagnose asthma more accurately

December 21, 2017, Elsevier
Obstruction of the lumen of a bronchiole by mucoid exudate, goblet cell metaplasia, and epithelial basement membrane thickening in a person with asthma. Credit: Yale Rosen/Wikipedia/CC BY-SA 2.0

Although about 24 million Americans are diagnosed with asthma every year, there is no single test that can diagnose the disease. Common symptoms, such as shortness of breath, wheezing, and cough, are relatively nonspecific, and physicians may use multiple tests and observations to reach an accurate diagnosis. In order to assess the accuracy and reliability of one of these tests that can be added to the clinician's toolbox to diagnose asthma - fractional exhaled nitric oxide (FeNO) concentration - researchers gathered and analyzed data from previous peer-reviewed studies. They conclude that the FeNO test has moderate accuracy for patients aged 5 and older. Their results are reported in Mayo Clinic Proceedings.

Researchers from the AHRQ-funded Evidence-based Practice Center at Mayo Clinic (Rochester, MN) identified 43 studies comprising a total of almost 14,000 adult and pediatric with suspected asthma who received the FeNO . This review was commissioned by AHRQ and the National Institutes of Health, National Heart, Lung, and Blood Institute, part of the U.S. Department of Health and Human Services.

"Asthma can sometimes be difficult to diagnose, and FeNO can be helpful to make therapeutic decisions more evidence based," explained lead investigator M. Hassan Murad, MD, MPH, of the Mayo Clinic. "In addition to a patient's history, the initial test is usually spirometry with an assessment of bronchodilator response. If this test does not confirm the , but the index of suspicion for asthma is still high, measurement of FeNO may be helpful to rule in disease; although will still miss some patients with asthma."

Investigators evaluated FeNO data from the selected studies and categorized the results into four cutoff values, less than 20 ppb, 20 to 29 ppb, 30 to 39 ppb, and 40 ppb and over. Patients were also divided into two age groups, those older than 18 and those aged between 5 and 18.

For patients over 18, sensitivity decreased from 0.80 at <20 ppb, 0.69 at 20-29 ppb, 0.53 at 30-39 ppb to 0.41 at >40 ppb. Specificity values were 0.64, 0.78, 0.85, and 0.93, respectively. Cutoff values change the sensitivity and specificity of the FeNO test. Lower cutoffs capture more people with disease but also cause more false positive results.

According to Dr. Murad, "There is no single test that can diagnose . FeNO may be a helpful tool that aids in diagnosis. However, patients' history, physical exam, response to treatment and other remain needed to complete the puzzle and make the diagnosis. Future research is needed to determine how FeNO can be used with other biomarkers with hopefully better accuracy that can provide a more definitive diagnosis."

Explore further: Decreased clot retraction rate in asthma

More information: Zhen Wang et al, The Diagnostic Accuracy of Fractional Exhaled Nitric Oxide Testing in Asthma: A Systematic Review and Meta-analyses, Mayo Clinic Proceedings (2017). DOI: 10.1016/j.mayocp.2017.11.012

Related Stories

Decreased clot retraction rate in asthma

November 7, 2016
(HealthDay)—Clot retraction rate (CRR) and fibrinolysis rate (FR) are reduced in steroid-naive asthma, according to a study published online Oct. 14 in Allergy.

ATS publishes clinical practice guidelines on interpretation of FENO levels

September 1, 2011
The American Thoracic Society has issued the first-ever guidelines on the use of fractional exhaled nitric oxide (FENO) that address when to use FENO and how to interpret FENO levels in different clinical settings. The guidelines, ...

Two tests in combination can provide better asthma diagnosis

September 24, 2013
It was previously thought that the two test methods signalled the same type of asthma. But a new study, led by researchers at Uppsala University, Sweden, shows that the methods actually signal two different inflammatory processes. ...

Study finds 33 percent of adults recently diagnosed with asthma do not have it

January 17, 2017
A new study published in the Journal of the American Medical Association found that 33 percent of adults recently diagnosed with asthma by their physicians did not have active asthma. Over 90 percent of these patients were ...

Recommended for you

Researchers identify source of molecule linked to nasal polyps, asthma attacks

May 23, 2018
A new discovery about how the immune system responds to common sinus infections and asthma could explain why patients develop these issues in the first place and ultimately may lead to improved targeted therapies. Researchers ...

Study demonstrates new treatment for severe asthma

May 22, 2018
Researchers from McMaster University and the Firestone Institute for Respiratory Health at St. Joseph's Healthcare Hamilton, together with colleagues at other partnering institutions, have developed a new method to treat ...

Eczema drug effective against severe asthma

May 21, 2018
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies. Dupilumab, an injectable ...

Neuron guidance factor found to play a key role in immune cell function

May 21, 2018
Macrophages are white blood cells involved in a variety of biological functions, from destroying infectious pathogens to repairing damaged tissue. To carry out their different roles, macrophages must first be activated and ...

Immune cells hold promise in slowing down ALS

May 21, 2018
Recent research from Houston Methodist Hospital showed that a new immunotherapy was safe for patients with ALS and also revealed surprising results that could bring hope to patients who have this relentlessly progressive ...

First clues to the causes of multiple sclerosis

May 16, 2018
Multiple sclerosis, which affects one in 1,000 people, is frequently characterised by relapses associated with variable functional impairments including among others vision problems, impairment of locomotor functions or difficulties ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.